Clinical Trial: Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Completely Resected Stage IB-IIIB Non-small-cell Lung Cancer

U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07039656) titled 'Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Completely Resected Stage IB-IIIB Non-small-cell Lung Cancer' on June 18.

Brief Summary: This is a single-arm, multicenter, Phase II study to evaluate the efficacy and safety of 3-4 cycles of toripalimab (JS001) plus chemotherapy and followed by toripalimab maintenance treatment up to one year in participants with Stage IB-IIIB non-small cell lung cancer (NSCLC) following completely resection, as measured by disease-free survival (DFS) and overall survival (OS).

Study Start Date: Jan. 01

Study Type: INTERVENTIONAL

Condition: Stage IB-IIIB NSCLC

Intervention: DRUG: ...